BACKGROUND: Dipyrone is an analgesic and antipyretic drug usually prescribed for patients with inflammatory conditions. We recently identified dipyrone as an antiapoptotic agent by screening a library of 1040 compounds for their ability to inhibit cytochrome c release from isolated mitochondria. OBJECTIVE: We investigated the potential neuroprotective properties of dipyrone in cerebral ischemia. METHODS: We evaluated the protective effects of dipyrone in experimental models of neuronal hypoxia/ischemia, including an oxygen/glucose deprivation model in primary cerebrocortical neurons and a focal cerebral ischemia model in mice. RESULTS: Dipyrone reduced hypoxia/ischemia injury in both cellular and animal models. Dipyrone inhibited the release of cytochrome c and other mitochondrial apoptogenic factors from mitochondria into the cytoplasm, and attenuated subsequent caspase-9 and caspase-3 activation both in vitro and in vivo. Moreover, dipyrone prevented ischemia-induced changes in Bcl-2 and tBid, and ameliorated oxygen/glucose deprivation-mediated loss of mitochondrial membrane potential. Dipyrone also inhibited ischemia-induced reactive microgliosis. In the cellular models evaluated, dipyrone did not inhibit oxygen/glucose deprivation-induced cyclooxygenase-2 activation. CONCLUSION: Dipyrone is remarkably neuroprotective in cerebral ischemia, and its cyclooxygenase-independent protective properties are, at least in part, due to the inhibition of mitochondrial cell death cascades.
BACKGROUND:Dipyrone is an analgesic and antipyretic drug usually prescribed for patients with inflammatory conditions. We recently identified dipyrone as an antiapoptotic agent by screening a library of 1040 compounds for their ability to inhibit cytochrome c release from isolated mitochondria. OBJECTIVE: We investigated the potential neuroprotective properties of dipyrone in cerebral ischemia. METHODS: We evaluated the protective effects of dipyrone in experimental models of neuronal hypoxia/ischemia, including an oxygen/glucose deprivation model in primary cerebrocortical neurons and a focal cerebral ischemia model in mice. RESULTS:Dipyrone reduced hypoxia/ischemia injury in both cellular and animal models. Dipyrone inhibited the release of cytochrome c and other mitochondrial apoptogenic factors from mitochondria into the cytoplasm, and attenuated subsequent caspase-9 and caspase-3 activation both in vitro and in vivo. Moreover, dipyrone prevented ischemia-induced changes in Bcl-2 and tBid, and ameliorated oxygen/glucose deprivation-mediated loss of mitochondrial membrane potential. Dipyrone also inhibited ischemia-induced reactive microgliosis. In the cellular models evaluated, dipyrone did not inhibit oxygen/glucose deprivation-induced cyclooxygenase-2 activation. CONCLUSION:Dipyrone is remarkably neuroprotective in cerebral ischemia, and its cyclooxygenase-independent protective properties are, at least in part, due to the inhibition of mitochondrial cell death cascades.
Authors: Bruce S Kristal; Irina G Stavrovskaya; Malini V Narayanan; Boris F Krasnikov; Abraham M Brown; M Flint Beal; Robert M Friedlander Journal: J Bioenerg Biomembr Date: 2004-08 Impact factor: 2.945
Authors: Shan Zhu; Irina G Stavrovskaya; Martin Drozda; Betty Y S Kim; Victor Ona; Mingwei Li; Satinder Sarang; Allen S Liu; Dean M Hartley; Du Chu Wu; Steven Gullans; Robert J Ferrante; Serge Przedborski; Bruce S Kristal; Robert M Friedlander Journal: Nature Date: 2002-05-02 Impact factor: 49.962
Authors: G E P De Souza; R A Cardoso; M C C Melo; A S C Fabricio; V M S Silva; M Lora; A J De Brum-Fernandes; G A Rae; S H Ferreira; A R Zampronio Journal: Inflamm Res Date: 2002-01 Impact factor: 4.575
Authors: Luca Scorrano; Scott A Oakes; Joseph T Opferman; Emily H Cheng; Mia D Sorcinelli; Tullio Pozzan; Stanley J Korsmeyer Journal: Science Date: 2003-03-06 Impact factor: 47.728
Authors: Yi Zhang; Anna Cook; Jinho Kim; Sergei V Baranov; Jiying Jiang; Karen Smith; Kerry Cormier; Erik Bennett; Robert P Browser; Arthur L Day; Diane L Carlisle; Robert J Ferrante; Xin Wang; Robert M Friedlander Journal: Neurobiol Dis Date: 2013-03-26 Impact factor: 5.996
Authors: Takashi D Y Kozai; Xia Li; Lance M Bodily; Ellen M Caparosa; Georgios A Zenonos; Diane L Carlisle; Robert M Friedlander; X Tracy Cui Journal: Biomaterials Date: 2014-08-28 Impact factor: 12.479
Authors: Mai M Al-Oqail; Nida N Farshori; Ebtesam S Al-Sheddi; Shaza M Al-Massarani; Maqsood A Siddiqui; Abdulaziz A Al-Khedhairy Journal: Mol Biol Rep Date: 2020-03-16 Impact factor: 2.316